1. Home
  2. About

Press Releases

Page Category: 
About

Sonosite Announces Transition Of Chief Financial Officer

Anil Amlani Appointed as New Chief Financial Officer Effective January 5th

BOTHELL, WA– December 27, 2011– Sonosite, Inc. (Nasdaq:SONO) , the world leader and specialist in bedside and point-of-care ultrasound, today announced that Marcus Smith will resign as Senior Vice President, Chief Financial Officer and Treasurer, effective as of January 2, 2012 and will be leaving the company effective as of January 5, 2012. Anil Amlani, the current President and Chief Executive Officer of Sonosite’s VisualSonics subsidiary, has been appointed the new Chief Financial Officer of Sonosite, effective as of January 2, 2012.

“Anil is a seasoned executive and operator, and is an ideal successor to serve as Sonosite’s new CFO,” said Kevin M. Goodwin, Sonosite’s President and CEO. “For the past 20 years, he has successfully led businesses. He also has served as a Chief Financial Officer for public and non-public companies for 11 years in total. More recently, Anil has led our VisualSonics business before and after the acquisition in June 2010. His broad experience base and global perspective will position Sonosite well.”

Read more

Sonosite Begins International Shipments Of New Edge Ultrasound System

New User Interface, Larger Screen Size and Exceptional Image Quality

BOTHELL, WA - December 21, 2011 - Sonosite, Inc. (Nasdaq:SONO) , the world leader and specialist in hand-carried ultrasound for the point-of-care, announced it has received CE Marking (Conformité Européenne) in the European Union to market its next generation point-of-care product: EDGE™ ultrasound system. The EDGE system is currently available for sale in the U.S., following receipt of FDA Premarket Notification 510(k) clearance in November. Sonosite is now commencing international customer deliveries.

Engineered with new state-of-the-art technology, the EDGE ultrasound system takes point-of- care ultrasound to a whole new level of clinical performance and enables physicians to deliver the highest standard of patient care by driving greater efficiencies and the potential for improved outcomes in the hospital and office.

The EDGE ultrasound was formally introduced this fall at medical meetings and congresses in Europe and Australia. Physicians positively responded to the system:

Read more

Fujifilm Holdings Announces Agreement to Acquire Sonosite, Inc.

Transaction combines high-quality imaging technologies and pioneering point-of-care expertise to drive next generation medical imaging solutions

Tokyo, Japan / Bothell, WA, U.S. – December 15, 2011 – FUJIFILM Holdings Corporation (TSE: 4901, hereinafter: Fujifilm), a diversified technology company that operates in healthcare, highly functional materials, and document solutions, announced today that it has entered into a definitive agreement with Sonosite, Inc. (NASDAQ: SONO, hereinafter: Sonosite), a pioneer and leader in bedside and point-of-care ultrasound technology, pursuant to which Fujifilm will acquire Sonosite for approximately $995 million (which includes amounts payable in connection with its convertible debt). The transaction was unanimously approved by the Boards of Directors of both companies.

Read more

Sonosite Introduces Next Generation Point-Of-Care Ultrasound Product: The EDGE Ultrasound System

Company Received FDA 510(k) Clearance and is Now Shipping the EDGE System to US Customers

BOTHELL, WA - November 17, 2011 - Sonosite, Inc. (Nasdaq:SONO) , the world leader and specialist in hand-carried ultrasound for the point-of-care, announced today that the company has received FDA 510(k) clearance for its fifth generation, high performance EDGE™ ultrasound system. Designed with physician feedback in mind, the EDGE system reaches a new level of clinical performance and product design, arming physicians with a tool to deliver better, safer and improved patient care. The company is now commencing US customer deliveries. International deliveries are pending CE marking.

“The EDGE system is a tremendous product and we are excited to bring it to point-of-care medicine, said Kevin M. Goodwin, Sonosite’s President and CEO. “We are encouraged by the timely regulatory review process, which represents a collaborative effort by many. We look forward to adding this new tool to our core markets and providing physicians with the impact they have been asking for in healthcare delivery.”

Read more

Sonosite Appoints Richard Salzar, Vice President, General Manager, Europe, Russia, And Africa

BOTHELL, WA– November 16, 2011– Sonosite, Inc. (Nasdaq:SONO) , the world leader and specialist in bedside and point-of-care ultrasound, today announced the appointment of Richard Salzar as the Vice President and General Manager of Europe, Russia, and Africa.

“Richard is a strong leader with 30 years of experience in the healthcare industry,” said Kevin M. Goodwin, Sonosite’s President and CEO. “As we continue to position ourselves for growth in our international markets, Richard’s past success at the strategic and business level will further strengthen our ability to expand our international footprint. We anticipate optimally structuring our approach for improved execution and growth heading into 2012.”

“Sonosite is a unique company with a superior product line and long-term market opportunity,” said Richard Salzar. “I’m excited for the opportunity to join the company and I’m confident in my ability to leverage our current resources internationally and drive strong results in the coming years.”

Read more

Sonosite Appoints Brian Noyes, 20 Year Veteran Of Johnson & Johnson, Vice President Of Marketing

BOTHELL, WA– November 15, 2011– Sonosite, Inc. (Nasdaq:SONO) , the world leader and specialist in bedside and point-of-care ultrasound, today announced the appointment of Brian Noyes as the Vice President of Marketing for North America and South America.

“Brian is an excellent addition to Sonosite and we welcome him to the leadership team,” said Matthew Damron, Sonosite’s Global Chief Marketing Officer. “He is an accomplished leader with decades of experience in the medical device industry, a successful product launch track record, and a key factor in the growth of a $1 billion franchise at Johnson & Johnson. Brian is a very appealing candidate to further elevate our marketing execution to the next level with expertise that is essential as we prepare to unleash the most exciting products in our company’s history.”

“Sonosite is a company with tremendous growth opportunities and has an enviable position in the healthcare industry,” said Brian Noyes. “I’m joining the company at a very exciting time, and I look forward to capitalizing on the current marketing initiatives, driving product demand, and market expansion.”

Read more

Sonosite Reports Third Quarter 2011 Results

Revenues Hit $75.7 Million in the Quarter, Up 10%

Year-to-Date Revenues Reach $219.5 Million, Up 18%

Conference Call Webcast Live Today at 1:30 pm Pacific/4:30 pm Eastern

BOTHELL, WA - October 25, 2011 - Sonosite, Inc. (Nasdaq:SONO) , the world leader and specialist in bedside and point-of-care ultrasound, today reported financial results for the third quarter and nine months ended September 30, 2011.

REVENUE

Revenues for the third quarter of 2011 were $75.7 million, rising 10% in comparison to $68.5 million in the third quarter of 2010.

Revenues for the nine months of 2011 were $219.5 million, compared to $186.1 million in 2010, an increase of 18%.

Overall order booking rates increased 16% in the quarter.

Foreign exchange contributed to a 2.1% favorable impact on third quarter results and a 2.8% favorable impact on the first nine months of 2011.

EBITDAS, EBITDA and OPERATING INCOME (EBIT)

Third Quarter:

For the quarter, EBITDAS includes non-recurring severance charges of $1.3 million from SG&A cost restructuring. Operating expense run rate savings are projected at $6.0 million for 2012, positioning the company for improved operating margins while launching new products and driving marketing initiatives in 2012.

Read more

Sonosite Provides M-Turbo Ultrasound Systems To Community Heart Screening For Students

Sponsored by Mt. Sinai Hospital, The Louis J. Acompora Memorial Foundation, and The Dominic A. Murray 21 Memorial Foundation

Free Screening October 22nd at Northport High School, Northport, New York

BOTHELL, WA - October 20, 2011 - Sonosite, Inc. (Nasdaq:SONO) , the world leader and specialist in bedside ultrasound for point-of-care medicine, proudly supports a community heart health screening to raise awareness and prevent sudden cardiac arrest in young adults.

Sponsored by the Louis J. Acompora Memorial Foundation , the Dominic A. Murray 21 Memorial Foundation and The Mount Sinai Hospital , the company will be providing physicians with its flagship M-Turbo ultrasound systems to perform a non-invasive cardiac ultrasound examination for the accurate evaluation of heart functionality, valve complications, and blood flow. Students between the ages of 14-24 are eligible for a free heart screening. The event will take place on October 22nd at the Northport High School in New York.

Read more

Sonosite Introduces The New BioZ Cardio Profile For Hemodynamic Monitoring In The Anesthesia Suite

A Tool to Improve Post-Operative Surgical Outcomes and Reduce Hospital Costs

Non-invasive System to Assist in Fluid Management

Technology Debuts at the 2011 American Society of Anesthesiologists Conference (ASA) October 15-17th, Booth #2242

BOTHELL, WA - October 13, 2011 - Sonosite, Inc. (Nasdaq:SONO) , the world leader and specialist in bedside and point-of-care ultrasound, today introduced the new BioZ® Cardio Profile system with impedance cardiography (ICG) technology for non-invasively monitoring a patient's hemodynamic profile in the hospital. Pioneered by NASA in the 1960's, ICG hemodynamic monitoring has traditionally been used to treat patients with heart failure and hypertension, and it is now ready to play a significant role in the anesthesia suite.

Read more

Sonosite Schedules Third Quarter 2011 Financial Release And Conference Call

BOTHELL, WA—October 6, 2011—Sonosite, Inc. (Nasdaq:SONO) , the world leader and specialist in bedside and point-of-care ultrasound, today announced that it will report the company's third quarter financial results on Tuesday, October 25, 2011 at the close of market and will host a conference call at 1:30 pm PT/4:30 ET. The call will be broadcast live and can be accessed via Sonosite's website at http://www.sonosite.com/about/investors .

A replay of the audio webcast will be available beginning October 25th at 4:30 pm PT and will be available until November 8th at 9:59 pm PT by dialing (719) 457-0820 or toll-free (888) 203-1112. The confirmation code 7745091 is required to access the replay. The call will also be archived on Sonosite's website.

About Sonosite

Sonosite, Inc. ( www.sonosite.com ) is the innovator and world leader in bedside and point-of-care ultrasound and an industry leader in ultra high-frequency micro-ultrasound technology and impedance cardiography equipment. Headquartered near Seattle, the company is represented by ten subsidiaries and a global distribution network in over 100 countries. Sonosite's small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high-performance ultrasound to the point of patient care.

Read more